AltavantSciences (@AltavantScience) header
AltavantSciences (@AltavantScience) profile picture

Altavant Sciences is a clinical stage biopharmaceutical company with an initial therapeutic focus in pulmonary arterial hypertension.

Joined February 2019
Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)Photo by AltavantSciences (@AltavantScience)
The 2022 Respiratory Innovation Summit will unite the innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly lung diseases. Happening May 13-14 in San Francisco. Register here: conference.thoracic.org/prog…
The #TourofPHenomenalHope is off to a great start. We have been given a challenge: if we can raise $5,000, we will be granted an additional generous donation of $10,000.
1
1
3
Registration is now open for #BID2020. Network and collaborate with others working in the field of medical countermeasures and #healthsecurity. @BARDA
Are you ready to learn more about opportunities to collaborate with BARDA, network with industry experts, and discuss the future of medical countermeasures? Registration is now open for #BID2020! Reserve your spot today. #healthsecurity medicalcountermeasures.gov/a…
1
2
AltavantSciences retweeted
.@BARDA is partnering with @Penn to develop a lung-on-a-chip. The new technology could help researchers better understand how the human lung reacts to toxic chlorine gas exposure & facilitate #innovative for treatments for other inhaled toxic chemicals. medicalcountermeasures.gov/n…
Awesome new episode! Brian Murray @uncrx_critcare joined me to talk all things related to Pulmonary Hypertension. From ICU supportive care, meds to avoid in PH, reviewing PH meds, transitions of care concerns, and so much more! Episode drops later this week. #PharmICU #TwitteRX
2
4
6
41
Alex was born with congenital heart disease and, like many with similar conditions, wonders how the coronavirus and COVID-19, the respiratory disease it causes, might affect him. Cardiologists are working on finding answers. spr.ly/60171QdYh
12
36
AltavantSciences retweeted
@phaware wants to share YOUR #pulmonaryhypertension story to over 110 countries across the world! We are currently interviewing patients, caregivers, & medical professionals for season 4 of our #phaware podcast series. Share your RARE: [email protected]
1
3
3
.Sumitomo Dainippon and @Roivant complete $3 billion deal thepharmaletter.com/article/… #biotech
Early diagnosis has always been a priority as #scleroderma patient outcomes are consistently better with early treatment. Lung Function Test May Offer Non-invasive Way to Detect Early #PAH in SSc Patients: sclerodermanews.com/2019/07/…
ATS News - Sneak Peek at Hot Topics at ATS 2019 news.thoracic.org/community/…
1
3
Today is #RareDiseaseDay 2019! For RTs, Pulmonary Fibrosis, Idiopathic Lung Disease, Pulmonary Hypertension #phaware, and LAM may top your rare-disease list for your patients. Thank you for all you do to help your patients! rarediseaseday.org/
10
11